Published in J Chromatogr on April 30, 1982
Reflections on my career in analytical chemistry and biochemistry. Proc Jpn Acad Ser B Phys Biol Sci (2010) 1.39
The utility of metabolomics in natural product and biomarker characterization. Biochim Biophys Acta (2014) 0.84
Structure of a lipid intermediate in cell wall peptidoglycan synthesis: a derivative of a C55 isoprenoid alcohol. Proc Natl Acad Sci U S A (1967) 4.15
Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood (1968) 2.71
The biosynthesis of mannosyl-1-phosphoryl-polyisoprenol in Micrococcus lysodeikticus and its role in mannan synthesis. Proc Natl Acad Sci U S A (1968) 2.30
Hemangioendothelial sarcoma of liver from chronic arsenic intoxication by Fowler's solution. Cancer (1968) 2.22
Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies. N Engl J Med (1975) 2.16
Quantitative determination of the neutral glycosyl ceramides in human blood. J Lipid Res (1967) 2.04
Amputation and adriamycin in primary osteosarcoma. N Engl J Med (1974) 2.04
An intensive sequenced adjuvant chemotherapy regimen for breast cancer. Cancer Invest (1993) 1.94
Oncologists' reply: survival expectancy in acute lymphocytic leukemia. N Engl J Med (1972) 1.89
Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med (1985) 1.83
Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. Blood (1982) 1.79
Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J Urol (2000) 1.78
Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. Ann Intern Med (1982) 1.75
Detection of mammary tumor virus env gene-like sequences in human breast cancer. Cancer Res (1995) 1.75
Elevated serum ribonuclease in patients with pancreatic cancer. Proc Natl Acad Sci U S A (1976) 1.74
Adjuvant chemotherapy of breast cancer. Cancer (1979) 1.73
Quantification of arabinitol in serum by selected ion monitoring as a diagnostic technique in invasive candidiasis. J Clin Microbiol (1980) 1.70
Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B. J Natl Cancer Inst (1996) 1.70
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B. Blood (1981) 1.68
An opportunistic infection with Corynebacterium pyogenes producing empyema. Am J Clin Pathol (1970) 1.62
Biosynthesis of the peptidoglycan of bacterial cell walls. XXI. Isolation of free C55-isoprenoid alcohol and of lipid intermediates in peptidoglycan synthesis from Staphylococcus aureus. J Biol Chem (1970) 1.60
A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B. J Clin Oncol (1989) 1.56
Reovirus infection of cancer cells is not due to activated Ras pathway. Cancer Gene Ther (2008) 1.56
Chemotherapy of acute lymphocytic leukemia of childhood. Cancer (1972) 1.50
The identification of trans-2-tetradecenoic acid in hydrolysates of lipid A from Escherichia coli. Biochim Biophys Acta (1972) 1.47
Management of hypocalcemic effects of WR2721 administered on a daily times five schedule with cisplatin and radiation therapy. The New York Gynecologic Oncology Group. J Clin Oncol (1993) 1.46
Diffuse pulmonary malignant mesothelioma: response to doxorubicin and 5-azacytidine. Cancer (1978) 1.45
Fluorometric investigations of the interaction of polyene antibiotics with sterols. Biochemistry (1972) 1.42
Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin Exp Metastasis (1999) 1.42
Diaminodichloroplatinum: a phase I study showing responses in testicular and other tumors. Cancer (1974) 1.42
Enzyme replacement in Fabry's disease, an inborn error of metabolism. Science (1970) 1.41
Analysis of acylcarnitines as their N-demethylated ester derivatives by gas chromatography-chemical ionization mass spectrometry. Anal Biochem (1991) 1.39
Zinc phosphide poisoning in a horse. Equine Vet J (1996) 1.38
Identification of a proviral structure in human breast cancer. Cancer Res (2001) 1.37
Mass spectrometric determination of unresolved components in gas chromatographic effluents. Anal Chem (1966) 1.36
Biochemical and pharmacological studies with asparaginase in man. Cancer Res (1970) 1.34
Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation). Am J Obstet Gynecol (1983) 1.33
Characterization of the iso-branched sphinganines from the ceramide phospholipids of Bacteroides melaninogenicus. Biochim Biophys Acta (1969) 1.32
Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia. Cancer Chemother Rep (1974) 1.30
Role of murine tumor models in cancer treatment research. Cancer Res (1986) 1.30
Lymphocyte function of Michigan dairy farmers exposed to polybrominated biphenyls. Science (1978) 1.30
A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients. Cancer (1973) 1.29
Glycosphingolipids: structure, biological source, and properties. Methods Enzymol (1989) 1.28
Melphalan in multiple myeloma. Blood (1967) 1.25
Surgical treatment of spinal cord compression from epidural metastasis. J Clin Oncol (1995) 1.25
The effectiveness of combinations of antileukemic agents in inducing and maintaining remission in children with acute leukemia. Blood (1965) 1.23
Structural characterization of oligosaccharides by high-performance liquid chromatography, fast-atom bombardment-mass spectrometry, and exoglycosidase digestion. Anal Biochem (1984) 1.23
Lateral diffusion in nuclear membranes. J Cell Biol (1985) 1.22
Enzyme therapy in Fabry disease: differential in vivo plasma clearance and metabolic effectiveness of plasma and splenic alpha-galactosidase A isozymes. Proc Natl Acad Sci U S A (1979) 1.21
Therapeutic effect and toxicity of adriamycin in patients with neoplastic disease. Cancer (1971) 1.21
The frequency of long-term remission in patients with acute myelogenous leukaemia treated with conventional maintenance chemotherapy: a study of 760 patients with a minimal follow-up time of 6 years. Br J Haematol (1989) 1.21
Increase of leukemia L1210 immunogenicity by Vibrio cholerae neuraminidase treatment. Cancer Res (1971) 1.20
Glycosphingolipids: structure, biological source, and properties. Methods Enzymol (1978) 1.17
Management of patients with malignant lymphoma: a comparative study with cyclophosphamide and vinca alkaloids. Cancer Res (1968) 1.16
Doxorubicin in disseminated osteosarcoma. JAMA (1972) 1.15
Triacontanol: a new naturally occurring plant growth regulator. Science (1977) 1.15
Improved chemotherapy for ovarian cancer with cis-diamminedichloroplatinum and adriamycin. Cancer (1981) 1.10
Chemistry and metabolism of sphingolipids. 3-Oxo derivatives of N-acetylsphingosine and N-acetyldihydrosphingosine. J Am Chem Soc (1966) 1.10
Epidemic acute leukemia. N Engl J Med (1970) 1.10
A phase I-II study of intensive-dose adriamycin for advanced breast cancer. J Clin Oncol (1987) 1.10
Ethics for a clinical investigator. Non primum non nocere. Am J Med (1979) 1.09
Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B. J Clin Oncol (1987) 1.08
Leukemia-specific DNA sequences in leukocytes of the leukemic member of identical twins. Proc Natl Acad Sci U S A (1973) 1.08
The measurement of dimethylamine, trimethylamine, and trimethylamine N-oxide using capillary gas chromatography-mass spectrometry. Anal Biochem (1990) 1.07
Search for mouse mammary tumor virus-like env sequences in cancer and normal breast from the same individuals. Clin Cancer Res (2001) 1.07
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study. J Clin Oncol (1996) 1.07
Pilot scale purification of alpha-galactosidase A from Cohn fraction IV-1 of human plasma. Biochim Biophys Acta (1978) 1.07
Vincristine treatment of advanced cancer: a cooperative study of 392 cases. Cancer Res (1973) 1.07
Editorial: Major advance in breast-cancer therapy. N Engl J Med (1976) 1.06
Possibilities of a viral etiology for human breast cancer. A review. Biol Trace Elem Res (1997) 1.06
Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine. Clin Cancer Res (1998) 1.06
Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes. Leukemia (1993) 1.05
Corticosteroid administration and localized leukocyte mobilization in man. N Engl J Med (1972) 1.05
MMTV-like env gene sequences in human breast cancer. Arch Virol (2001) 1.05
Venous thrombosis during multimodal treatment of primary breast carcinoma. Cancer Treat Rep (1981) 1.04
The prophylactic treatment of thrombocytopenic leukemic patients with platelets: a double blind study. Transfusion (1974) 1.04
Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trial. Ann Intern Med (1982) 1.03
Glycolipid and mucopolysaccharide abnormality in fibroblasts of fabry's disease. Science (1969) 1.03
Structural studies of urinary oligosaccharides from patients with mannosidosis. Arch Biochem Biophys (1981) 1.03
Kinetic and comparative studies on localized leukocyte mobilization in normal man. J Lab Clin Med (1969) 1.03
Growth control of human foreskin fibroblasts and inhibition of extracellular sialidase activity by 2-deoxy-2,3-dehydro-N-acetylneuraminic acid. J Biol Chem (1988) 1.03
A method for the quantitative determination of neutral glycosphingolipids in urine sediment. J Lipid Res (1970) 1.03
5-allyl-2'-deoxyuridine inhibition of nucleoside phosphorylase in HeLa cells containing mycoplasma. Cancer Res (1967) 1.02
Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance. Cancer (1974) 1.02
Concentrations of glycosyl ceramides in plasma and red cells in Fabry's disease, a glycolipid lipidosis. J Lipid Res (1969) 1.02
Diamminodichloroplatinum in the chemotherapy of testicular tumors. J Urol (1974) 1.02
Analysis of trimethylsilyl O-methyloximes of carbohydrates by combined gas-liquid chromatography-mass spectrometry. Anal Biochem (1971) 1.01
Lipids trigger changes in the elasticity of the cytoskeleton in plant cells: a cell optical displacement assay for live cell measurements. J Cell Biol (1994) 1.01
The variability of individual tolerance to methotrexate in cancer patients. Br J Cancer (1971) 1.01
Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts. Endocrinology (1998) 0.99
Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study. J Clin Oncol (1988) 0.99
Determination of polyols in serum by selected ion monitoring. Clin Chem (1984) 0.98
Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture. Cancer Res (1988) 0.98
Bile acid composition of bile from germ-free rabbits. Biochim Biophys Acta (1969) 0.98
Prostacyclin and thromboxane A2 formation is increased in human sepsis syndrome. Effects of cyclooxygenase inhibition. Am Rev Respir Dis (1991) 0.98
Experiemental and clinical studies on muramidase (lysozyme). I. Muramidase activity of normal human blood cells and inflammatory exudates. Acta Haematol (1970) 0.97
Incomplete fatty acid oxidation by ischemic heart: beta-hydroxy fatty acid production. Am J Physiol (1980) 0.96
Sequences homologous to the mouse mammary tumor virus env gene in human breast carcinoma correlate with overexpression of laminin receptor. Clin Cancer Res (1999) 0.96
Gas chromatography and mass spectrometry of sphingolipid bases. Characterization of sphinga-4,14-dienine from plasma sphingomyelin. Biochemistry (1968) 0.96